Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study.
Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study.
复制标题
肥胖状况和代谢综合征与特定部位癌症的关联:基于人群的队列研究
DOI:
10.1038/s41416-020-1012-6
复制
发表时间:
2020-10
影响因子:
8.8
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Cao Z;Zheng X;Yang H;Li S;Xu F;Yang X;Wang Y
BackgroundObesity and metabolic syndrome (MetS) appear in clusters and are both associated with an increased risk of cancer. However, it remains unknown whether obesity status with or without MetS increases the risk of site-specific cancers.MethodsWe used data derived from 390,575 individuals (37–73 years old) from the UK Biobank who were enrolled from 2006–2016 with a median of 7.8 years of follow-up. Obesity was defined by BMI ≥ 30 kg/m2and MetS was defined by the criteria of the Adult Treatment Panel-III (ATP-III). Cox proportional hazards models were used to investigate the associations of BMI and MetS with 22 cancers.ResultsMetabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) phenotypes represented 6.7% and 17.9% of the total analytic samples and 27.1% and 72.9% of the included subpopulation with obesity, respectively. Obesity was independently associated with higher risks of 10 of 22 cancers. Stratified by metabolic status, the MUO phenotype was consistently associated with 10 obesity-related cancers. In contrast, the MHO phenotype was only associated with increased risks of five cancers: endometrium, oesophagus, kidney, pancreas and postmenopausal breast cancers.ConclusionEven in metabolically healthy individuals, obesity was associated with increased risks of five cancers, whereas we did not find that these individuals were associated with increased risks of several other obesity-related cancers.
登录
查看更多内容
DOI:
10.1158/1055-9965.epi-14-0240
发表时间:
2014-10
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Moore LL;Chadid S;Singer MR;Kreger BE;Denis GV
通讯作者:
Denis GV
影响因子:
39.3
作者:
Lassale C;Tzoulaki I;Moons KGM;Sweeting M;Boer J;Johnson L;Huerta JM;Agnoli C;Freisling H;Weiderpass E;Wennberg P;van der A DL;Arriola L;Benetou V;Boeing H;Bonnet F;Colorado-Yohar SM;Engström G;Eriksen AK;Ferrari P;Grioni S;Johansson M;Kaaks R;Katsoulis M;Katzke V;Key TJ;Matullo G;Melander O;Molina-Portillo E;Moreno-Iribas C;Norberg M;Overvad K;Panico S;Quirós JR;Saieva C;Skeie G;Steffen A;Stepien M;Tjønneland A;Trichopoulou A;Tumino R;van der Schouw YT;Verschuren WMM;Langenberg C;Di Angelantonio E;Riboli E;Wareham NJ;Danesh J;Butterworth AS
通讯作者:
Butterworth AS
影响因子:
5.6
作者:
Janssen, I;Katzmarzyk, PT;Ross, R
通讯作者:
Ross, R
影响因子:
6.4
作者:
Guo W;Key TJ;Reeves GK
通讯作者:
Reeves GK
影响因子:
6.9
作者:
Choromanska, Barbara;Mysliwiec, Piotr;Miklosz, Agnieszka
通讯作者:
Miklosz, Agnieszka